Literature DB >> 7685319

The reactivity of sera from chagasic patients against different fragments of cruzipain, the major cysteine proteinase from Trypanosoma cruzi, suggests the presence of defined antigenic and catalytic domains.

J Martínez1, O Campetella, A C Frasch, J J Cazzulo.   

Abstract

Three fragments of cruzipain, expressed separately in bacterial vectors, were used to detect antibodies in sera from patients with chronic Chagas' disease. Most antibodies directed against the enzyme were found to react with the C-terminal extension, thus suggesting the presence of immunodominant B-cell epitopes within this protein domain. Immunoprecipitation with these antibodies did not impair enzyme activity. It is suggested that cruzipain consists of an enzymatic domain and a non-enzymatic, immunodominant domain, which corresponds to the C-terminal extension.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685319     DOI: 10.1016/0165-2478(93)90090-o

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

1.  Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.

Authors:  Maximiliano R Ferrero; Anja M Heins; Luciana L Soprano; Diana M Acosta; Mónica I Esteva; Thomas Jacobs; Vilma G Duschak
Journal:  Med Microbiol Immunol       Date:  2015-06-06       Impact factor: 3.402

2.  Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50.

Authors:  M A Curtis; A Thickett; J M Slaney; M Rangarajan; J Aduse-Opoku; P Shepherd; N Paramonov; E F Hounsell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 3.  Intermediate metabolism in Trypanosoma cruzi.

Authors:  J J Cazzulo
Journal:  J Bioenerg Biomembr       Date:  1994-04       Impact factor: 2.945

4.  Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.

Authors:  Anita R Schnapp; Chris S Eickhoff; Donata Sizemore; Roy Curtiss; Daniel F Hoft
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

5.  Ligand-induced conformational selection predicts the selectivity of cysteine protease inhibitors.

Authors:  Geraldo Rodrigues Sartori; Andrei Leitão; Carlos A Montanari; Charles A Laughton
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

6.  Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease.

Authors:  Luciana L Soprano; Maximiliano R Ferrero; Malena Landoni; Gabriela A García; Mónica I Esteva; Alicia S Couto; Vilma G Duschak
Journal:  Front Cell Infect Microbiol       Date:  2022-01-04       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.